- Home
- GAMB vs SCPH Comparison
GAMB vs SCPH Comparison
Compare GAMB & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAMB
- SCPH
- Stock Information
- Founded
- GAMB 2006
- SCPH 2013
- Country
- GAMB Jersey
- SCPH United States
- Employees
- GAMB N/A
- SCPH N/A
- Industry
- GAMB Services-Misc. Amusement & Recreation
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- GAMB Consumer Discretionary
- SCPH Health Care
- Exchange
- GAMB Nasdaq
- SCPH Nasdaq
- Market Cap
- GAMB 338.0M
- SCPH 274.7M
- IPO Year
- GAMB 2021
- SCPH 2017
- Fundamental
- Price
- GAMB $14.63
- SCPH $3.14
- Analyst Decision
- GAMB Strong Buy
- SCPH Strong Buy
- Analyst Count
- GAMB 6
- SCPH 2
- Target Price
- GAMB $15.83
- SCPH $15.00
- AVG Volume (30 Days)
- GAMB 383.2K
- SCPH 404.8K
- Earning Date
- GAMB 11-14-2024
- SCPH 11-13-2024
- Dividend Yield
- GAMB N/A
- SCPH N/A
- EPS Growth
- GAMB 306.73
- SCPH N/A
- EPS
- GAMB 0.78
- SCPH N/A
- Revenue
- GAMB $124,404,000.00
- SCPH $30,278,000.00
- Revenue This Year
- GAMB $18.54
- SCPH $174.12
- Revenue Next Year
- GAMB $11.87
- SCPH $133.41
- P/E Ratio
- GAMB $18.86
- SCPH N/A
- Revenue Growth
- GAMB 27.63
- SCPH 303.87
- 52 Week Low
- GAMB $7.52
- SCPH $3.08
- 52 Week High
- GAMB $16.09
- SCPH $6.71
- Technical
- Relative Strength Index (RSI)
- GAMB 62.26
- SCPH 36.30
- Support Level
- GAMB $12.54
- SCPH $3.16
- Resistance Level
- GAMB $16.09
- SCPH $3.67
- Average True Range (ATR)
- GAMB 0.78
- SCPH 0.23
- MACD
- GAMB 0.11
- SCPH -0.01
- Stochastic Oscillator
- GAMB 58.86
- SCPH 4.35
About GAMB Gambling.com Group Limited
Gambling.com Group Ltd is a multi-award-winning performance marketing company and a provider of digital marketing services in the online gambling industry. Its principal focus is on online casino and online sports betting and the fantasy sports industry. It generates revenue by referring online gamblers to online gambling operators.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.